Pregnancy
Hemodynamic instability
Body mass index greater than 40 kg / m2
Use of intravenous amiodarone or lidocaine in the last 24 hours
Acute coronary syndrome
Presence of tachycardia with irregular or supraventricular RR
Contraindications to study drugs

NCT03299517_exc_T1
Condition
Pregnancy
NCT03299517_exc_T2
Condition
Hemodynamic instability
NCT03299517_exc_T3
Measurement
Body mass index
NCT03299517_exc_T4
Value
greater than 40 kg / m2
NCT03299517_exc_T5
Qualifier
intravenous
NCT03299517_exc_T6
Drug
amiodarone
NCT03299517_exc_T7
Drug
lidocaine
NCT03299517_exc_T8
Temporal
in the last 24 hours
NCT03299517_exc_T9
Scope
amiodarone or lidocaine
NCT03299517_exc_T10
Condition
Acute coronary syndrome
NCT03299517_exc_T11
Condition
tachycardia
NCT03299517_exc_T12
Condition
ular or s nt
NCT03299517_exc_T13
Condition
supraventricular RR
NCT03299517_exc_T14
Condition
Contraindications
NCT03299517_exc_T15
Drug
study drugs